Join us for this Science Talk with Drs. Ali Salanti, Max M Søgaard, and Louise Leth Hefting on development of a virus-like particle (VLP)-based COVID-19 vaccine and what the companies behind it, AdaptVac and ExpreS²ion Biotechnologies, have done to fast-track their developmental pipeline.

Presenter:

• Max M Søgaard, PhD, Vice President at ExpreS²ion Biotechnologies ApS.
• Ali Salanti, PhD, Professor of Translational Microbiology; Co-Founder & Board Member at AdaptVac ApS
• Louise Leth Hefting, PhD, Field Application Scientist at ChemoMetec A/S
• Janny Marie L Peterslund, PhD, Scientific Affairs Manager at ChemoMetec A/S

Join us for this Science Talk with Drs. Ali Salanti, Max M Søgaard, and Louise Leth Hefting on development of a virus-like particle (VLP)-based COVID-19 vaccine and what the companies behind it, AdaptVac and ExpreS²ion Biotechnologies, have done to fast-track their developmental pipeline.

In this science talk you’ll learn:

• Learn about the capsid VLP and ExpreS2™ technologies
• Get the insights on fast-tracking a COVID-19 vaccine
• What did AdaptVac and EspreS²ion learn through this developmental work?
• How did they work with industry partner ChemoMetec?
• What are Salanti and Søgaard’s take on the COVID-19 vaccine landscape?

Duration: 36 minutes